Innoviva (INVA) Payables (2010 - 2026)
Innoviva (INVA) reported Payables of $6.5 million for Q1 2026, up 38.68% on a YoY basis from $4.7 million in Q1 2025, and up 31.25% quarter-over-quarter from $5.0 million in Q4 2025.
Innoviva (INVA) Payables (2010 - 2026) Analysis & Trends
Innoviva has reported Payables for 17 years, with the latest figure at $6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 38.68% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 38.68% YoY), and the FY2025 full-year result was $5.0 million, up 132.93% from the prior year.
- Payables for Q1 2026 stood at $6.5 million, up from $5.0 million in the prior quarter.
- The five-year high for Payables was $6.7 million in Q4 2023, with the low at $890000.0 in Q1 2024.
- Historically, Payables has averaged $4.2 million across 5 years, with a median of $4.3 million in 2022.
- Annual changes were most pronounced in 2022 — Payables surged 14310.0% — and 2024, when it plunged 85.0%.
- Innoviva's Payables stood at $2.9 million in 2022, then surged by 128.55% to $6.7 million in 2023, then sank by 68.26% to $2.1 million in 2024, then soared by 132.93% to $5.0 million in 2025, then soared by 31.25% to $6.5 million in 2026.
- The last three Payables figures came in at $6.5 million (Q1 2026), $5.0 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 34.55 Mn |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.52 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 890,000.00 |
| Dec 31, 2023 | 6.72 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | 30,000.00 |